CDK5 and Alzheimer disease: Our results are interesting because, in CP-AD subjects, we found decreased levels of nuclear Cdk5 and p27 and increased nuclear E2F1, suggesting a loss of the cell-cycle suppression function in demented individuals (CP-AD) compared to nondemented individuals (P-AD and N).